Vistagen Therapeutics (VTGN) EBT Margin (QoQ) (2011 - 2026)
Vistagen Therapeutics (VTGN) EBT Margin (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Vistagen Therapeutics | 10.41 Mn | 10.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 273,428.00 |
| Dec 31, 2025 | 128,868.00 |
| Sep 30, 2025 | -133,949.00 |
| Jun 30, 2025 | -9.70 Mn |
| Mar 31, 2025 | 9.68 Mn |
| Dec 31, 2024 | 105,775.00 |
| Sep 30, 2024 | 569,869.00 |
| Jun 30, 2024 | -794,489.00 |
| Mar 31, 2024 | -328,748.00 |
| Dec 31, 2023 | 65,099.00 |
| Sep 30, 2023 | 125,400.00 |
| Jun 30, 2023 | 349,659.00 |
| Mar 31, 2023 | -152,370.00 |
| Dec 31, 2022 | -346,508.00 |
| Sep 30, 2022 | 441,782.00 |
| Jun 30, 2022 | 3.64 Mn |
| Mar 31, 2022 | -3.98 Mn |
| Dec 31, 2021 | 63,156.00 |
| Sep 30, 2021 | -138,702.00 |
| Jun 30, 2021 | -78,180.00 |